Beijing Aosaikang Pharmaceutical Co., Ltd. (002755) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beijing Aosaikang Pharmaceutical Co., Ltd.

Why is Beijing Aosaikang Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -15.24% and Operating profit at -20.32% over the last 5 years

Flat results in Mar 26

INTEREST COVERAGE RATIO(Q) Lowest at 8,688.9
INTEREST(Q) Highest at CNY 1.18 MM

With ROE of 7.74%, it has a expensive valuation with a 3.56 Price to Book Value

Over the past year, while the stock has generated a return of -7.68%, its profits have risen by 82% ; the PEG ratio of the company is 0.6
At the current price, the company has a high dividend yield of 0.9

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 16.83% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -7.68% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Aosaikang Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Beijing Aosaikang Pharmaceutical Co., Ltd.

-37.7%

1.21

45.66%

China Shanghai Composite

3.0%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-15.24%

EBIT Growth (5y)

-20.32%

EBIT to Interest (avg)

-3.01

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.71

Sales to Capital Employed (avg)

0.54

Tax Ratio

14.98%

Dividend Payout Ratio

47.08%

Pledged Shares

Institutional Holding

ROCE (avg)

10.43%

ROE (avg)

7.19%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.51

EV to EBIT

35.60

EV to EBITDA

25.49

EV to Capital Employed

11.08

EV to Sales

5.21

PEG Ratio

0.55

Dividend Yield

0.96%

ROCE (Latest)

31.13%

ROE (Latest)

7.74%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by 1.59% (YoY

CASH AND EQV(HY)

Highest at CNY 4,815.9 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.57 times

-24What is not working for the Company

INTEREST(HY)

At CNY 1.18 MM has Grown at 84.93%

NET PROFIT(Q)

At CNY 32.85 MM has Fallen at -48.51%

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.34 times

NET SALES(Q)

At CNY 389.27 MM has Fallen at -11.14%

OPERATING PROFIT(Q)

Lowest at CNY 56.16 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 14.43 %

PRE-TAX PROFIT(Q)

Lowest at CNY 31.81 MM

Here's what is working for Beijing Aosaikang Pharmaceutical Co., Ltd.

Cash and Eqv

Highest at CNY 4,815.9 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 2.57 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by 1.59% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Beijing Aosaikang Pharmaceutical Co., Ltd.

Interest

At CNY 1.18 MM has Grown at 84.93%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY 31.81 MM has Fallen at -58.03%

over average net sales of the previous four periods of CNY 75.8 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 32.85 MM has Fallen at -48.51%

over average net sales of the previous four periods of CNY 63.8 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

At CNY 389.27 MM has Fallen at -11.14%

over average net sales of the previous four periods of CNY 438.06 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 56.16 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 14.43 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 31.81 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Debtors Turnover Ratio

Lowest at 5.34 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading